1. Home
  2. KRRO vs INTT Comparison

KRRO vs INTT Comparison

Compare KRRO & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$12.66

Market Cap

150.0M

Sector

Health Care

ML Signal

HOLD

Logo inTest Corporation

INTT

inTest Corporation

HOLD

Current Price

$16.73

Market Cap

175.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRRO
INTT
Founded
2014
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
150.0M
175.3M
IPO Year
2019
1997

Fundamental Metrics

Financial Performance
Metric
KRRO
INTT
Price
$12.66
$16.73
Analyst Decision
Buy
Strong Buy
Analyst Count
12
2
Target Price
$34.80
$13.50
AVG Volume (30 Days)
144.5K
244.4K
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,392,000.00
$66,801,000.00
Revenue This Year
N/A
$15.82
Revenue Next Year
N/A
$9.10
P/E Ratio
N/A
N/A
Revenue Growth
181.46
66.06
52 Week Low
$5.20
$5.56
52 Week High
$55.89
$19.75

Technical Indicators

Market Signals
Indicator
KRRO
INTT
Relative Strength Index (RSI) 47.56 55.86
Support Level $12.51 $7.33
Resistance Level $14.76 N/A
Average True Range (ATR) 0.77 1.41
MACD -0.19 0.01
Stochastic Oscillator 10.05 38.64

Price Performance

Historical Comparison
KRRO
INTT

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

About INTT inTest Corporation

inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.

Share on Social Networks: